Progress in the determination of the J/ψ−πJ/\psi-\pi cross section

Improving previous calculations, we compute the $J/\psi \pi\to {charmed mesons}$ cross section using QCD sum rules. Our sum rules for the $J/\psi \pi\to \bar{D} D^*$, $D \bar{D}^*$, ${\bar D}^* D^*$ and ${\bar D} D$ hadronic matrix elements are constructed by using vaccum-pion correlation functions, and we work up to twist-4 in the soft-pion limit. Our results suggest that, using meson exchange models is perfectly acceptable, provided that they include form factors and that they respect chiral symmetry. After doing a thermal average we get $\sim 0.3$ mb at T=150\MeV.Comment: 22 pages, RevTeX4 including 7 figures in ps file

Run-Time Assertion Checking of Data- and Protocol-Oriented Properties of Java Programs: An Industrial Case Study

Run-time assertion checking is one of the useful techniques for detecting faults, and can be applied during any program execution context, including debugging, testing, and production. In general, however, it is limited to checking state-based properties. We introduce SAGA, a general framework that provides a smooth integration of the specification and the run-time checking of both data- and protocol-oriented properties of Java classes and interfaces. We evaluate SAGA, which combines several state-of-the art tools, by conducting an industrial case study from an eCommerce software company Fredhopper

Dissociation cross sections of ground-state and excited charmonia with light mesons in the quark model

We present numerical results for the dissociation cross sections of ground-state, orbitally- and radially-excited charmonia in collisions with light mesons. Our results are derived using the nonrelativistic quark model, so all parameters are determined by fits to the experimental meson spectrum. Examples of dissociation into both exclusive and inclusive final states are considered. The dissociation cross sections of several C=(+) charmonia may be of considerable importance for the study of heavy ion collisions, since these states are expected to be produced more copiously than the J/psi. The relative importance of the productions of ground-state and orbitally-excited charmed mesons in a pion-charmonium collision is demonstrated through the $\sqrt {s}$-dependent charmonium dissociation cross sections.Comment: 9 pages, 8 figure

Measurement of the Intrinsic Radiopurity of Cs-137/U-235/U-238/Th-232 in CsI(Tl) Crystal Scintillators

The inorganic crystal scintillator CsI(Tl) has been used for low energy neutrino and Dark Matter experiments, where the intrinsic radiopurity is an issue of major importance. Low-background data were taken with a CsI(Tl) crystal array at the Kuo-Sheng Reactor Neutrino Laboratory. The pulse shape discrimination capabilities of the crystal, as well as the temporal and spatial correlations of the events, provide powerful means of measuring the intrinsic radiopurity of Cs-137 as well as the U-235, U-238 and Th-232 series. The event selection algorithms are described, with which the decay half-lives of Po-218, Po-214, Rn-220, Po-216 and Po-212 were derived. The measurements of the contamination levels, their concentration gradients with the crystal growth axis, and the uniformity among different crystal samples, are reported. The radiopurity in the U-238 and Th-232 series are comparable to those of the best reported in other crystal scintillators. Significant improvements in measurement sensitivities were achieved, similar to those from dedicated massive liquid scintillator detector. This analysis also provides in situ measurements of the detector performance parameters, such as spatial resolution, quenching factors, and data acquisition dead time.Comment: 28 pages, 12 figure

Charmonium - Pion Cross Section from QCD Sum Rules

The $J/\psi \pi\to \bar{D} D^*, \bar{D} D$, ${\bar D}^* D^*$ and ${\bar D} D^*$ cross sections as a function of $\sqrt{s}$ are evaluated in a QCD sum rule calculation. We study the Borel sum rule for the four point function involving pseudoscalar and vector meson currents, up to dimension four in the operator product expansion. We find that our results are smaller than the $J/\psi \pi\to {charmed mesons}$ cross sections obtained with models based on meson exchange, but are close to those obtained with quark exchange models.Comment: revised version accepted for publication in Phys. Lett.

Detecting autoreactive B cells in the peripheral blood of people with type 1 diabetes using ELISpot

Type 1 diabetes mellitus (T1D) is an autoimmune disorder where T lymphocytes damage the islet beta cells but B lymphocytes also play an important role. Although changes in peripheral B cell phenotype have been observed, little is known about the B cells that secrete the autoantibodies. We developed a sensitive B cell enzyme-linked immunospot assay (ELISpot assay) to detect individual B cell antibody responses to glutamic acid decarboxylase (GAD) and islet antigen-2 (IA-2). We found that even healthy donors have B cells that secrete antibodies in response to GAD and IA-2 in the ELISpot. There was increased B cell reactivity to autoantigens in the peripheral blood of individuals with newly-diagnosed, but not long-standing, type 1 diabetes. However, no correlation with serum autoantibody levels was found, indicating that additional factors such as antigen affinity or exposure to antigens in vivo are required for antibody secretion, and that even healthy donors have potentially autoreactive B cells

Testing abstract behavioral specifications

We present a range of testing techniques for the Abstract Behavioral Specification (ABS) language and apply them to an industrial case study. ABS is a formal modeling language for highly variable, concurrent, component-based systems. The nature of these systems makes them susceptible to the introduction of subtle bugs that are hard to detect in the presence of steady adaptation. While static analysis techniques are available for an abstract language such as ABS, testing is still indispensable and complements analytic methods. We focus on fully automated testing techniques including black-box and glass-box test generation as well as runtime assertion checking, which are shown to be effective in an industrial setting

Conjugation of a peptide autoantigen to gold nanoparticles for intradermally administered antigen specific immunotherapy

Antigen specific immunotherapy aims to tolerise patients to specific autoantigens that are responsible for the pathology of an autoimmune disease. Immune tolerance is generated in conditions where the immune response is suppressed and thus gold nanoparticles (AuNPs) are an attractive drug delivery platform due to their anti-inflammatory effects and their potential to facilitate temporal and spatial delivery of a peptide autoantigen in conjunction with pro-tolerogenic elements. In this study we have covalently attached an autoantigen, currently under clinical evaluation for the treatment of type 1 diabetes (PIC19-A3 peptide), to AuNPs to create nanoscale (<5 nm), negatively charged (−40 to −60 mV) AuNP-peptide complexes for immunotherapy. We also employ a clinically approved microneedle delivery system, MicronJet600, to facilitate minimally-invasive intradermal delivery of the nanoparticle constructs to target skin-resident antigen presenting cells, which are known to be apposite target cells for immunotherapy. The AuNP-peptide complexes remain physically stable upon extrusion through microneedles and when delivered into ex vivo human skin they are able to diffuse rapidly and widely throughout the dermis (their site of deposition) and, perhaps more surprisingly, the overlying epidermal layer. Intracellular uptake was extensive, with Langerhans cells proving to be the most efficient cells at internalising the AuNP-peptide complex (94% of the local population within the treated region of skin). In vitro studies showed that uptake of the AuNP-peptide complexes by dendritic cells reduced the capacity of these cells to activate naïve T cells. This indicator of biological functionality encourages further development of the AuNP-peptide formulation, which is now being evaluated in clinical trials